Lakefront Biotherapeutics Nv

This study follows about 546 people who have already received a Galapagos CAR T-cell therapy for blood cancers. Researchers will track them for 15 years to check for long-term side effects, how long the treatment lasts in the body, and overall survival. No new treatment is given—…